Skip to main content

Find Clinical Trials

Home
Conditions
Pancreatic Diseases

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,387 public trials 842 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

NCT00966277

Conditions: Cardiovascular Diseases, Digestive System Diseases, Digestive System Neoplasms, +17 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Backpack Carrying in Children With Cystic Fibrosis

NCT02700282

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +9 more
Locations: Le Havre Hospital Le Havre, France

View Trial Details

Completed

PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL

NCT01393249

Conditions: Acute Lymphoblastic Leukemia, Digestive System Diseases, Hematologic Diseases, +12 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma

NCT01410968

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Completed

Early Palliative Care on Quality of Life of Advanced Cancer Patients

NCT02988635

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +23 more
Locations: Not specified

View Trial Details

Completed

Study of GLPG1837 in Subjects With Cystic Fibrosis (G551D Mutation)

NCT02707562

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Royal Adelaide Hospital Adelaide, Australia

The Prince Charles Hospital Chermside, Australia

Monash Medical Centre Clayton, Australia

Sir Charles Gairdner Hospital Nedlands, Australia

View all 16 locations

View Trial Details

Completed

Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer

NCT00059826

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University of Florida Shands Cancer Center Gainesville, Florida, United States

Rush University Medical Center Chicago, Illinois, United States

James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View all 14 locations

View Trial Details

Completed

Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer

NCT02984501

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Completed

Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis

NCT00850551

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: University of Washington Seattle, Washington, United States

View Trial Details

Completed

Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma

NCT02977702

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +5 more
Locations: Not specified

View Trial Details